COVID-19–Associated Miller Fisher Syndrome: MRI Findings

References

1. 1.↵
   1. Gutierrez-Ortiz C,
   2. Mendez A,
   3. Rodrigo-Rey S, et al

   . Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 2020 Apr 17. [Epub ahead of print] doi:10.1212/WNL.0000000000009619 pmid:32303650

   CrossRefPubMed
2. 2.↵
   1. Filatov A,
   2. Sharma P,
   3. Hindi F, et al

   . Neurological complications of coronavirus (COVID19): encephalopathy. Cureus 2020;12:e7352 doi:10.7759/cureus.7352

   CrossRefPubMed
3. 3.↵
   1. Poyiadji N,
   2. Shahin G,
   3. Noujaim D, et al

   . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 Mar 31. [Epub ahead of print] doi:10.1148/radiol.2020201187 pmid:32228363

   CrossRefPubMed
4. 4.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020 Apr 10. [Epub ahead of print] doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
5. 5.↵
   1. Bukhari S,
   2. Taboada J

   . A case of Miller Fisher syndrome and literature review. Cureus 2017;9:e1048 doi:10.7759/cureus.1048

   CrossRef
6. 6.↵
   1. Mori M,
   2. Kuwabara S,
   3. Fukutake T, et al

   . Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104–06 doi:10.1212/wnl.56.8.1104 pmid:11320188

   Abstract/FREE Full Text
7. 7.↵
   1. Nishimoto Y,
   2. Odaka M,
   3. Hirata K, et al

   . Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 2004;148:200–05 doi:10.1016/j.jneuroim.2003.11.017 pmid:14975602

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Snyder LA,
   2. Rismondo V,
   3. Miller NR

   . The Fisher variant of Guillain-Barre syndrome (Fisher syndrome). J Neuroophthalmol 2009;29:312–24 doi:10.1097/WNO.0b013e3181c2514b pmid:19952907

   CrossRefPubMed
9. 9.↵
   1. de Silva NL,
   2. Weeratunga P,
   3. Umapathi T, et al

   . Miller Fisher syndrome developing as a parainfectious manifestation of dengue fever: a case report and review of the literature. J Med Case Rep 2019;13:120 doi:10.1186/s13256-019-2066-z pmid:31043165

   CrossRefPubMed
10. 10.↵
    1. Conde Cardona G,
    2. Quintana Pájaro LD,
    3. Quintero Marzola ID, et al

    . Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci 2020;412:116824 doi:10.1016/j.jns.2020.116824 pmid:32299010

    CrossRefPubMed